The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS‐BPH)

Studies have shown that 48.59% of benign prostate hyperplasia (BPH) is combined with metabolic syndrome (MetS). The mainstream view supports the correlation between MetS and BPH, but the pathogenesis of MetS‐BPH is not fully understood. Four hundred and seventy‐four men, aged 47 years or older, were...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Z.P., Yan, Y., Chen, C.J., Li, M., Chen, C., Zhao, S.C., Song, T., Liu, T., Zou, C.H., Xu, Q., Li, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646917/
https://www.ncbi.nlm.nih.gov/pubmed/29873201
http://dx.doi.org/10.1111/andr.12498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646917/
https://www.ncbi.nlm.nih.gov/pubmed/29873201
http://dx.doi.org/10.1111/andr.12498

Ejemplares similares